New Zealand Government Allocates $216 Million for Tobacco Tax Cut

Jul.30.2024
New Zealand Government Allocates $216 Million for Tobacco Tax Cut
New Zealand government to allocate $216 million for heated tobacco products tax cut, despite concerns over potential health risks.

According to RNZ on July 30th, the New Zealand government has agreed to set aside $216 million for the necessary expenses related to reducing taxes on heated tobacco products (HTP).


RNZ reported earlier this month that New Zealand's Deputy Minister of Health and Minister of Customs, Casey Costello, has implemented a 50% reduction in the excise tax on HTP. Costello's office did not disclose how much government funding this measure would cost, but a Cabinet document released on the Ministry of Health's website shows that the Cabinet agreed in May to reserve $216 million as an emergency fund to compensate for the anticipated loss of revenue.


The tobacco giant Philip Morris has previously lobbied for tax cuts on this, with its IQOS product dominating the HTP market in New Zealand.


A cabinet document signed by New Zealand First Party MP Casey Costello shows that it is unclear whether this tax cut will be passed on to consumers.


The document indicates that...


It is not yet clear whether the reduction of the HTP consumption tax will benefit consumers through lower retail prices, as the product currently holds a monopoly market in New Zealand.


Costello declined to be interviewed by RNZ, and her office did not respond to questions about whether the monopoly referred to Philip Morris.


The minister stated in a declaration that she expects the industry to decrease the costs of its products.


This means I hope that the reduction in consumption tax can be passed on to consumers, as officials have suggested will happen, and we will also monitor this.


She also stated that she does not expect government spending to "approach the modeled amount" because the tax revenue collected from the HTP in 2022 is only 3.62 million dollars, compared to 5.97 million dollars in 2023.


Officials point out that there is a great deal of uncertainty in the models and financial impact, as it is based on the rapid growth of HTP usage in Japan, where e-cigarettes are still unavailable for purchase.


Philip Morris did not respond to RNZ's questions.


Since the New Zealand First Party made concessions in their coalition agreement with the National Party, which included repealing recent tobacco laws, the media and tobacco researchers have been emphasizing the connection between the company and the New Zealand First Party.


Two senior corporate communication positions at Philip Morris were filled by individuals who had previously held senior positions in the New Zealand First party.


The minister stated that she has no connections to the industry and has not discussed policy-making with tobacco lobbyists.


Earlier this year, the minister canceled a law that would have reduced the number of tobacco retailers from 6000 to 600, removed 95% of nicotine from cigarettes, and set a goal of creating a smoke-free generation by prohibiting the sale of cigarettes to those born after 2009.


The New Zealand government has stated that it remains committed to achieving the smoke-free goal by 2025, which aims to have fewer than 5% of New Zealanders smoking daily. Currently, 6.8% of New Zealanders smoke daily, down from 16.4% in 2012.


Costello previously stated that she hopes to provide people with more options to quit smoking, and believes that lowering the price of HTPs can encourage more people to use them.


Health ministry officials warned the minister not to relax regulation on HTP before the consumption tax reduction.


There is no evidence to support the use of HTP as a smoking cessation tool, so we do not recommend relaxing the promotion of HTP. This could exacerbate existing issues of youth attraction to and addiction to nicotine products.


Even Costello's cabinet documents acknowledge that there is no strong evidence to suggest that HTP is safe.


Due to its relatively new market, there is still no clear evidence indicating that HTP significantly reduces harm compared to traditional cigarettes.


However, in her statement to RNZ, Costello stated that the risks of HTP are similar to those of e-cigarettes.


According to a Cabinet document, modeling from the Department of Health suggests that if prices were lowered, it is possible that 7,200 smokers could switch to HTP within two years.


Reducing the consumption tax on HTP may increase its attractiveness to smokers who have not successfully transitioned to e-cigarettes, as canceling the consumption tax may make these products cheaper than they currently are.


As we have seen in e-cigarette products, we need to closely monitor the potential use of HTP by non-smokers, especially adolescents, due to the lower prices.


Due to being relatively new, research on HTP as a smoking cessation or transition tool is limited. However, overall, feedback from smokers and quit smoking services indicates that providing more choices for smokers to transition away from tobacco supports New Zealand in achieving its smoke-free goal.


A one-year trial will be conducted to evaluate whether a reduction in consumption tax helps people quit smoking.


This review will also provide us with an opportunity to determine whether non-smokers, especially young people, are using heated tobacco products so that we can quickly respond when necessary.


The document also notes that the measure to reduce consumption tax does not meet the standards required by the Cabinet for such proposals, as it fails to provide a regulatory impact statement.


On the contrary, the regulatory department and the health department will conduct a "post-implementation review" of the reduction in consumption tax one year later.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT said it will begin rolling out “EVO Sakura Regular,” a new product under the premium EVO brand for the heated tobacco brand Ploom, at convenience stores and tobacco retailers across Japan from April 6. The product has already been on sale since February 3 through the CLUB JT online shop and Ploom Shops nationwide.
Mar.13 by 2FIRSTS.ai
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
On March 13, 2026, R.J. Reynolds and related companies filed an appeal with the U.S. Court of Appeals for the Federal Circuit, seeking review of the U.S. International Trade Commission’s final ruling in the disposable vape Section 337 investigation.
Mar.16 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Smoore International Reports 2025 Revenue of RMB 14.256 Billion, Up 20.8%
Smoore International Reports 2025 Revenue of RMB 14.256 Billion, Up 20.8%
On March 17, Smoore International Holdings Limited released its annual results for the year ended December 31, 2025. Revenue reached RMB 14.256 billion, up 20.8% year on year. Gross profit was RMB 4.857 billion, with a gross margin of 34.1%. Profit for the year was RMB 1.062 billion, down 18.5%, while adjusted profit for the year was RMB 1.530 billion, up 1.3%. By segment, revenue from enterprise customers was RMB 11.344 billion and revenue from own-brand business was RMB 2.912 billion.
Mar.18 by 2FIRSTS.ai
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai